Baillie Gifford's position in Thermo Fisher Scientific is currently worth $337M. That's 0.27% of their equity portfolio (64th largest holding). The first Thermo Fisher Scientific trade was made in Q4 2017. Since then Baillie Gifford bought shares four more times and sold shares on 29 occasions. The stake costed the investor $165M, netting the investor a gain of 104% so far.